Comparing Semaglutide vs Tradjenta
| Semaglutide | Tradjenta (linagliptin) |
|
|---|
| Semaglutide | Tradjenta (linagliptin) |
|
|||||||
|---|---|---|---|---|---|---|---|---|---|
|
Prescription only
Semaglutide (Ozempic, Rybelsus) lowers blood sugar levels by mimicking the effects of GLP-1, a naturally occurring hormone that stimulates insulin secretion and lowers glucagon secretion from the... View more |
Prescription only
Prescribed for Type 2 Diabetes. Tradjenta may also be used for purposes not listed in this medication guide. |
Related suggestions Popular comparisons
|
|||||||
| More about Semaglutide | More about Tradjenta (linagliptin) | ||||||||
| Ratings & Reviews | |||||||||
|
Semaglutide has an average rating of 6.9 out of 10 from a total of 2690 ratings on Drugs.com. 56% of reviewers reported a positive effect, while 20% reported a negative effect. |
Tradjenta has an average rating of 3.5 out of 10 from a total of 74 ratings on Drugs.com. 22% of reviewers reported a positive effect, while 69% reported a negative effect. |
||||||||
| Side Effects Experienced by Users Side effects are reported in Drugs.com user reviews and not clinically verified. | |||||||||
View all Semaglutide side effects |
View all Tradjenta side effects |
||||||||
| Drug Class | |||||||||
| Generic Availability | |||||||||
|
N/A |
|||||||||
| Pricing and Coupons * Prices are without insurance | |||||||||
|
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
View all Tradjenta prices |
||||||||
| Dosage Forms | |||||||||
|
N/A |
|
||||||||
| Brand Names | |||||||||
| Ozempic, Rybelsus, Wegovy |
N/A |
||||||||
| Half Life Drug half-life is the time required for plasma concentration to reduce to half its original value. | |||||||||
|
168 hours |
12 hours |
||||||||
| CSA Schedule 1 View glossary of CSA terms | |||||||||
|
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||
| Pregnancy Category | |||||||||
|
Summary unavailable. See the full pregnancy warnings document. |
Category B
No proven risk in humans
See the full pregnancy warnings document. |
||||||||
| Drug Interactions | |||||||||
|
A total of 273 drugs are known to interact with Semaglutide:
|
A total of 349 drugs are known to interact with Tradjenta:
|
||||||||
| Alcohol/Food/Lifestyle Interactions | |||||||||
|
|||||||||
| Disease Interactions | |||||||||
| First Approval Date | |||||||||
|
December 05, 2017 |
May 02, 2011 |
||||||||
| WADA Class View classifications | |||||||||
|
N/A |
N/A |
||||||||
| More Information | |||||||||
| Patient Resources | |||||||||
| Professional Resources | |||||||||
| Related Treatment Guide | |||||||||
1 The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
See also:
Mounjaro
Mounjaro is used for type 2 diabetes to help lower blood sugar levels. Mounjaro has also been shown ...
Rybelsus
Rybelsus tablets are used to improve blood sugar control in adults with type 2 diabetes, and may ...
Ozempic
Learn about Ozempic (semaglutide) for type 2 diabetes treatment, weight management, cardiovascular ...
Zepbound
Zepbound (tirzepatide) is an FDA-approved weekly injection for weight loss and obstructive sleep ...
Wegovy
Wegovy (semaglutide) an FDA-approved weekly injection for weight loss and to reduce heart risks ...
Victoza
Victoza helps control blood sugar levels and reduce the risk of serious heart problems in people ...
Saxenda
Saxenda (liraglutide) injection is used for weight loss in obese or overweight patients. Includes ...
Alli
alli blocks the absorption of some of the fat that you eat and is used to treat obesity. Learn ...
Amphetamine
Amphetamine is a stimulant and is used to trat narcolepsy and attention deficit disorder. Includes ...
Tirzepatide
Tirzepatide is a once-weekly injection used for weight loss, sleep apnea, and type 2 diabetes ...
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.